Value Partners Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150,000	Closed	-$366K	–	68
2021 Q4	$366K	Buy	150,000 +30,000	+25%	+$73.2K	0.03%	65
2021 Q3	$301K	Hold	120,000	–	–	0.03%	70
2021 Q2	$342K	Buy	+120,000	New	+$342K	0.03%	66